(VIANEWS) – Bebe stores (BEBE), Invesco Pennsylvania Value Municipal Income Trust (VPV), Smith & Nephew (SNN) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Bebe stores (BEBE)
776.29% Payout Ratio
bebe stores, inc. does not have significant operations. Previously, it was engaged in the design, development, and production of women's apparel and accessories. The company marketed its products under the bebe and BEBE SPORT brand names through its retail stores; bebe.com, an online store; and 39 bebe outlet stores. It also offered its products through its 82 international licensee operated stores in 22 countries. bebe stores, inc. was founded in 1976 and is headquartered in Brisbane, California.
Earnings Per Share
As for profitability, Bebe stores has a trailing twelve months EPS of $-0.05.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -43.18%.
Volume
Today’s last reported volume for Bebe stores is 4055 which is 261.73% above its average volume of 1121.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Bebe stores’s EBITDA is -68.3.
2. Invesco Pennsylvania Value Municipal Income Trust (VPV)
497% Payout Ratio
Invesco Pennsylvania Value Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade Pennsylvania municipal securities which include municipal bonds, municipal notes, municipal commercial paper, and lease obligations. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was formerly known as Invesco Van Kampen Pennsylvania Value Municipal Income Trust. Invesco Pennsylvania Value Municipal Income Trust was formed on April 30, 1993 and is domiciled in the United States.
Earnings Per Share
As for profitability, Invesco Pennsylvania Value Municipal Income Trust has a trailing twelve months EPS of $-0.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.71%.
3. Smith & Nephew (SNN)
150% Payout Ratio
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Earnings Per Share
As for profitability, Smith & Nephew has a trailing twelve months EPS of $0.5.
PE Ratio
Smith & Nephew has a trailing twelve months price to earnings ratio of 51.04. Meaning, the purchaser of the share is investing $51.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.1%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Oct 4, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 3.47%.
Yearly Top and Bottom Value
Smith & Nephew’s stock is valued at $25.52 at 16:23 EST, way under its 52-week high of $33.09 and way above its 52-week low of $21.52.
Volume
Today’s last reported volume for Smith & Nephew is 343323 which is 76.37% below its average volume of 1452960.
4. Morgan Stanley India Investment Fund (IIF)
117.15% Payout Ratio
Morgan Stanley India Investment Fund, Inc. is a closed ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. The fund is co-managed by Morgan Stanley Investment Management Company. It invests in the public equity markets of India. The fund invests in stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the U.S. dollar adjusted BSE National Index. Morgan Stanley India Investment Fund, Inc. was formed on December 22, 1993 and is domiciled in the United States.
Earnings Per Share
As for profitability, Morgan Stanley India Investment Fund has a trailing twelve months EPS of $3.36.
PE Ratio
Morgan Stanley India Investment Fund has a trailing twelve months price to earnings ratio of 6.64. Meaning, the purchaser of the share is investing $6.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.75%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 14, 2022, the estimated forward annual dividend rate is 3.98 and the estimated forward annual dividend yield is 18.17%.
Moving Average
Morgan Stanley India Investment Fund’s worth is higher than its 50-day moving average of $22.19 and above its 200-day moving average of $21.05.
5. Patterson Companies (PDCO)
47.49% Payout Ratio
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Earnings Per Share
As for profitability, Patterson Companies has a trailing twelve months EPS of $2.19.
PE Ratio
Patterson Companies has a trailing twelve months price to earnings ratio of 14.21. Meaning, the purchaser of the share is investing $14.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
Yearly Top and Bottom Value
Patterson Companies’s stock is valued at $31.13 at 16:23 EST, below its 52-week high of $34.53 and way above its 52-week low of $25.15.
Moving Average
Patterson Companies’s value is higher than its 50-day moving average of $30.01 and higher than its 200-day moving average of $29.32.
Previous days news about Patterson Companies (PDCO)
- According to Zacks on Wednesday, 15 November, "Some better-ranked stocks from the same medical industry are Cardinal Health (CAH Quick QuoteCAH – Free Report) , Biodesix (BDSX Quick QuoteBDSX – Free Report) and Patterson Companies (PDCO Quick QuotePDCO – Free Report) , each carrying a Zacks Rank #2 (Buy) at present. "
- According to Zacks on Friday, 17 November, "Some other top-ranked stocks from the same medical industry are Cardinal Health (CAH Quick QuoteCAH – Free Report) , Biodesix (BDSX Quick QuoteBDSX – Free Report) and Patterson Companies (PDCO Quick QuotePDCO – Free Report) , each carrying a Zacks Rank #2 at present. "
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
